Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Dermatologists should consider congenital syndromes like TRPS in young adults with early hair loss.

Different hair loss types need accurate diagnosis for proper treatment.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Early intervention and continuous treatment are key for managing hereditary hair loss effectively.

Early hair loss may predict heart disease.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

The machine learning model effectively assesses the severity of hair loss and could help dermatologists with treatment decisions.

Autologous stem cell therapy may effectively increase hair density in Androgenetic Alopecia.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Gene variations may increase oxidative stress in male pattern baldness.

Hair transplants make people look more attractive, successful, approachable, and younger.

ATG effectively reduces hair frizz without damaging hair strength.

Standardized PRP therapy can improve treatment for hair loss.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Isoproterenol may help treat hair loss by activating hair follicle stem cells.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Thorough scalp examination is crucial for diagnosing alopecia areata incognita in men with diffuse hair loss.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

The solution increased hair density safely and effectively for hair loss.

New regenerative therapies show promise for treating hair loss.

Hair loss gene linked to prostate issues.

More severe hair loss and longer treatment improve results.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

The treatment increased hair growth and thickness in patients with hair loss.